Skip to content
10-K

Annual Report

ARCTURUS THERAPEUTICS HOLDINGS INC. ARCT

0001193125-26-088391

← back to feed
Filed
Mar 3, 2026 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2025 · Feb 27, 2026 28.42M sh
Shares Diluted FY 2025 · Dec 31, 2025 27.39M sh
Shares Diluted FY 2025 · Dec 31, 2024 27M sh
Shares Diluted FY 2025 · Dec 31, 2023 26.63M sh
Capex FY 2025 · Dec 31, 2025 $230K
Capex FY 2025 · Dec 31, 2024 $648K
Capex FY 2025 · Dec 31, 2023 $2.9M
Operating Cash Flow FY 2025 · Dec 31, 2025 −$74.27M
Operating Cash Flow FY 2025 · Dec 31, 2024 −$59.75M
Operating Cash Flow FY 2025 · Dec 31, 2023 −$18.1M
Cash And Equivalents FY 2025 · Dec 31, 2025 $230.91M
Cash And Equivalents FY 2025 · Dec 31, 2024 $237.03M
Cash And Equivalents FY 2025 · Dec 31, 2023 $292.01M
Stockholders Equity FY 2025 · Dec 31, 2025 $213.99M
Stockholders Equity FY 2025 · Dec 31, 2024 $240.98M
Stockholders Equity FY 2025 · Dec 31, 2023 $278.51M
Stockholders Equity FY 2025 · Dec 31, 2022 $270.31M
Current Liabilities FY 2025 · Dec 31, 2025 $36.38M
Current Liabilities FY 2025 · Dec 31, 2024 $65.49M
Total Liabilities FY 2025 · Dec 31, 2025 $57.16M
Total Liabilities FY 2025 · Dec 31, 2024 $103.09M
Current Assets FY 2025 · Dec 31, 2025 $241.45M
Current Assets FY 2025 · Dec 31, 2024 $305.98M
Total Assets FY 2025 · Dec 31, 2025 $271.15M
Total Assets FY 2025 · Dec 31, 2024 $344.07M
Eps Diluted FY 2025 · Dec 31, 2025 −$2.40
Eps Diluted FY 2025 · Dec 31, 2024 −$3.00
Eps Diluted FY 2025 · Dec 31, 2023 −$1.12
Eps Basic FY 2025 · Dec 31, 2025 −$2.40
Eps Basic FY 2025 · Dec 31, 2024 −$3.00
Eps Basic FY 2025 · Dec 31, 2023 −$1.12
Sga Expense FY 2025 · Dec 31, 2025 $46.08M
Sga Expense FY 2025 · Dec 31, 2024 $52.82M
Sga Expense FY 2025 · Dec 31, 2023 $52.87M
Rd Expense FY 2025 · Dec 31, 2025 $112.21M
Rd Expense FY 2025 · Dec 31, 2024 $195.16M
Rd Expense FY 2025 · Dec 31, 2023 $192.13M
Net Income FY 2025 · Dec 31, 2025 −$65.78M
Net Income FY 2025 · Dec 31, 2024 −$80.94M
Net Income FY 2025 · Dec 31, 2023 −$29.73M
Operating Income FY 2025 · Dec 31, 2025 −$76.26M
Operating Income FY 2025 · Dec 31, 2024 −$95.67M
Operating Income FY 2025 · Dec 31, 2023 −$78.21M
Revenue FY 2025 · Dec 31, 2025 $82.03M
Revenue FY 2025 · Dec 31, 2024 $152.31M
Revenue FY 2025 · Dec 31, 2023 $166.8M